TR
Transgene S.A.
TRGNF · OTC
$1.00 +0.00% (+$0.00)
Market Cap 114.2M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
3 /100
Expensive P/B 7.51x
P/S 17.97x
PEG N/A
Growth
0 /100
Declining Book val. growth 16.80%
Rev. growth 38.28%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 419.06%
Op. margin 561.28%
Gross margin 439.56%
Quality
3 /100
Poor ROA 80.55%
Asset turnover 0.15x
ROIC 125.69%
Debt
67 /100
Low Net debt/EBITDA 0.24x
Int. coverage -16.62x
Debt/Equity 0.68x
Stability
46 /100
Moderate Profitable years 0
EPS volatility 30.20%
Beta 0.68x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TRGNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alessandro Riva
Employees
156
Headquarters
Illkirch-Graffenstaden
Nadcházející události
24 ZÁŘ
Earnings
Upcoming earnings report